UniProt ID | CDC37_HUMAN | |
---|---|---|
UniProt AC | Q16543 | |
Protein Name | Hsp90 co-chaperone Cdc37 | |
Gene Name | CDC37 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 378 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Co-chaperone that binds to numerous kinases and promotes their interaction with the Hsp90 complex, resulting in stabilization and promotion of their activity. [PubMed: 8666233 Inhibits HSP90AA1 ATPase activity] | |
Protein Sequence | MVDYSVWDHIEVSDDEDETHPNIDTASLFRWRHQARVERMEQFQKEKEELDRGCRECKRKVAECQRKLKELEVAEGGKAELERLQAEAQQLRKEERSWEQKLEEMRKKEKSMPWNVDTLSKDGFSKSMVNTKPEKTEEDSEEVREQKHKTFVEKYEKQIKHFGMLRRWDDSQKYLSDNVHLVCEETANYLVIWCIDLEVEEKCALMEQVAHQTIVMQFILELAKSLKVDPRACFRQFFTKIKTADRQYMEGFNDELEAFKERVRGRAKLRIEKAMKEYEEEERKKRLGPGGLDPVEVYESLPEELQKCFDVKDVQMLQDAISKMDPTDAKYHMQRCIDSGLWVPNSKASEAKEGEEAGPGDPLLEAVPKTGDEKDVSV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MVDYSVWD -------CCCCCCCC | 4.70 | 19413330 | |
2 | Acetylation | ------MVDYSVWDH ------CCCCCCCCC | 10.73 | 19413330 | |
4 | Phosphorylation | ----MVDYSVWDHIE ----CCCCCCCCCCC | 8.16 | 23663014 | |
5 | Phosphorylation | ---MVDYSVWDHIEV ---CCCCCCCCCCCC | 16.56 | 22115753 | |
13 | Phosphorylation | VWDHIEVSDDEDETH CCCCCCCCCCCCCCC | 26.93 | 30266825 | |
19 | Phosphorylation | VSDDEDETHPNIDTA CCCCCCCCCCCCCHH | 55.76 | 23663014 | |
25 | Phosphorylation | ETHPNIDTASLFRWR CCCCCCCHHHHHHHH | 17.85 | 30266825 | |
27 | Phosphorylation | HPNIDTASLFRWRHQ CCCCCHHHHHHHHHH | 30.08 | 28450419 | |
45 | Acetylation | ERMEQFQKEKEELDR HHHHHHHHHHHHHHH | 72.54 | 19608861 | |
60 | Acetylation | GCRECKRKVAECQRK HHHHHHHHHHHHHHH | 31.15 | 26051181 | |
67 | Ubiquitination | KVAECQRKLKELEVA HHHHHHHHHHHHHHH | 37.72 | - | |
69 | Malonylation | AECQRKLKELEVAEG HHHHHHHHHHHHHHC | 64.39 | 26320211 | |
69 | Acetylation | AECQRKLKELEVAEG HHHHHHHHHHHHHHC | 64.39 | 26051181 | |
69 | 2-Hydroxyisobutyrylation | AECQRKLKELEVAEG HHHHHHHHHHHHHHC | 64.39 | - | |
69 | Ubiquitination | AECQRKLKELEVAEG HHHHHHHHHHHHHHC | 64.39 | - | |
78 | Acetylation | LEVAEGGKAELERLQ HHHHHCCHHHHHHHH | 49.93 | 19608861 | |
93 | Ubiquitination | AEAQQLRKEERSWEQ HHHHHHHHHHHHHHH | 72.95 | - | |
97 | Phosphorylation | QLRKEERSWEQKLEE HHHHHHHHHHHHHHH | 37.94 | 26714015 | |
101 | Acetylation | EERSWEQKLEEMRKK HHHHHHHHHHHHHHH | 46.48 | 26822725 | |
101 | Malonylation | EERSWEQKLEEMRKK HHHHHHHHHHHHHHH | 46.48 | 26320211 | |
101 | Ubiquitination | EERSWEQKLEEMRKK HHHHHHHHHHHHHHH | 46.48 | 21890473 | |
110 | Acetylation | EEMRKKEKSMPWNVD HHHHHHHHCCCCCHH | 62.02 | 25953088 | |
110 | 2-Hydroxyisobutyrylation | EEMRKKEKSMPWNVD HHHHHHHHCCCCCHH | 62.02 | - | |
110 | Ubiquitination | EEMRKKEKSMPWNVD HHHHHHHHCCCCCHH | 62.02 | 21890473 | |
111 | Phosphorylation | EMRKKEKSMPWNVDT HHHHHHHCCCCCHHH | 31.04 | 28857561 | |
112 | Sulfoxidation | MRKKEKSMPWNVDTL HHHHHHCCCCCHHHC | 7.07 | 30846556 | |
118 | Phosphorylation | SMPWNVDTLSKDGFS CCCCCHHHCCCCCCC | 28.75 | 28348404 | |
120 | Phosphorylation | PWNVDTLSKDGFSKS CCCHHHCCCCCCCHH | 30.69 | 25159151 | |
121 | Acetylation | WNVDTLSKDGFSKSM CCHHHCCCCCCCHHH | 66.05 | 26822725 | |
121 | Ubiquitination | WNVDTLSKDGFSKSM CCHHHCCCCCCCHHH | 66.05 | 21890473 | |
125 | Phosphorylation | TLSKDGFSKSMVNTK HCCCCCCCHHHCCCC | 29.38 | 23186163 | |
126 | Ubiquitination | LSKDGFSKSMVNTKP CCCCCCCHHHCCCCC | 40.07 | - | |
126 | Acetylation | LSKDGFSKSMVNTKP CCCCCCCHHHCCCCC | 40.07 | 25953088 | |
127 | Phosphorylation | SKDGFSKSMVNTKPE CCCCCCHHHCCCCCC | 27.11 | 25849741 | |
128 | Sulfoxidation | KDGFSKSMVNTKPEK CCCCCHHHCCCCCCC | 2.87 | 30846556 | |
131 | Phosphorylation | FSKSMVNTKPEKTEE CCHHHCCCCCCCCCC | 36.24 | 24043423 | |
132 | Sumoylation | SKSMVNTKPEKTEED CHHHCCCCCCCCCCC | 46.07 | - | |
132 | Sumoylation | SKSMVNTKPEKTEED CHHHCCCCCCCCCCC | 46.07 | - | |
132 | Acetylation | SKSMVNTKPEKTEED CHHHCCCCCCCCCCC | 46.07 | 25953088 | |
135 | Ubiquitination | MVNTKPEKTEEDSEE HCCCCCCCCCCCHHH | 70.53 | 21890473 | |
136 | Phosphorylation | VNTKPEKTEEDSEEV CCCCCCCCCCCHHHH | 42.83 | 23312004 | |
140 | Phosphorylation | PEKTEEDSEEVREQK CCCCCCCHHHHHHHH | 38.65 | 25849741 | |
149 | 2-Hydroxyisobutyrylation | EVREQKHKTFVEKYE HHHHHHHHHHHHHHH | 51.17 | - | |
154 | Malonylation | KHKTFVEKYEKQIKH HHHHHHHHHHHHHHH | 54.10 | 26320211 | |
154 | 2-Hydroxyisobutyrylation | KHKTFVEKYEKQIKH HHHHHHHHHHHHHHH | 54.10 | - | |
154 | Acetylation | KHKTFVEKYEKQIKH HHHHHHHHHHHHHHH | 54.10 | 19608861 | |
155 | Phosphorylation | HKTFVEKYEKQIKHF HHHHHHHHHHHHHHH | 18.17 | 28152594 | |
157 | Acetylation | TFVEKYEKQIKHFGM HHHHHHHHHHHHHCC | 54.99 | 23749302 | |
157 | Ubiquitination | TFVEKYEKQIKHFGM HHHHHHHHHHHHHCC | 54.99 | - | |
227 | Acetylation | LELAKSLKVDPRACF HHHHHHCCCCHHHHH | 52.24 | 25953088 | |
240 | Acetylation | CFRQFFTKIKTADRQ HHHHHHHHHHHHCHH | 36.73 | 19608861 | |
246 | Methylation | TKIKTADRQYMEGFN HHHHHHCHHHHCCCH | 27.37 | - | |
249 | Sulfoxidation | KTADRQYMEGFNDEL HHHCHHHHCCCHHHH | 2.84 | 28465586 | |
260 | Acetylation | NDELEAFKERVRGRA HHHHHHHHHHHHHHH | 52.22 | 27452117 | |
260 | Ubiquitination | NDELEAFKERVRGRA HHHHHHHHHHHHHHH | 52.22 | 21890473 | |
273 | Acetylation | RAKLRIEKAMKEYEE HHHHHHHHHHHHHHH | 51.95 | 25953088 | |
278 | Phosphorylation | IEKAMKEYEEEERKK HHHHHHHHHHHHHHH | 24.11 | 28796482 | |
298 | Phosphorylation | GLDPVEVYESLPEEL CCCHHHHHHHCHHHH | 6.06 | 28796482 | |
300 | Phosphorylation | DPVEVYESLPEELQK CHHHHHHHCHHHHHH | 31.38 | 25849741 | |
307 | Ubiquitination | SLPEELQKCFDVKDV HCHHHHHHCCCHHHH | 49.87 | - | |
308 | S-nitrosylation | LPEELQKCFDVKDVQ CHHHHHHCCCHHHHH | 1.96 | 19483679 | |
308 | Glutathionylation | LPEELQKCFDVKDVQ CHHHHHHCCCHHHHH | 1.96 | 22555962 | |
308 | S-nitrosocysteine | LPEELQKCFDVKDVQ CHHHHHHCCCHHHHH | 1.96 | - | |
312 | Acetylation | LQKCFDVKDVQMLQD HHHCCCHHHHHHHHH | 54.77 | 26051181 | |
312 | Ubiquitination | LQKCFDVKDVQMLQD HHHCCCHHHHHHHHH | 54.77 | - | |
316 | Sulfoxidation | FDVKDVQMLQDAISK CCHHHHHHHHHHHHC | 3.49 | 21406390 | |
322 | Phosphorylation | QMLQDAISKMDPTDA HHHHHHHHCCCHHHH | 24.53 | 23911959 | |
323 | Ubiquitination | MLQDAISKMDPTDAK HHHHHHHCCCHHHHH | 41.01 | 21890473 | |
323 | 2-Hydroxyisobutyrylation | MLQDAISKMDPTDAK HHHHHHHCCCHHHHH | 41.01 | - | |
330 | Acetylation | KMDPTDAKYHMQRCI CCCHHHHHHHHHHHH | 38.20 | 23749302 | |
330 | 2-Hydroxyisobutyrylation | KMDPTDAKYHMQRCI CCCHHHHHHHHHHHH | 38.20 | - | |
330 | Ubiquitination | KMDPTDAKYHMQRCI CCCHHHHHHHHHHHH | 38.20 | 21906983 | |
336 | Glutathionylation | AKYHMQRCIDSGLWV HHHHHHHHHHCCCCC | 1.97 | 22555962 | |
336 | S-nitrosylation | AKYHMQRCIDSGLWV HHHHHHHHHHCCCCC | 1.97 | 19483679 | |
336 | S-nitrosocysteine | AKYHMQRCIDSGLWV HHHHHHHHHHCCCCC | 1.97 | - | |
339 | Phosphorylation | HMQRCIDSGLWVPNS HHHHHHHCCCCCCCC | 18.84 | - | |
346 | Phosphorylation | SGLWVPNSKASEAKE CCCCCCCCCHHHCCC | 24.43 | 27251275 | |
347 | Ubiquitination | GLWVPNSKASEAKEG CCCCCCCCHHHCCCC | 63.67 | - | |
352 | Ubiquitination | NSKASEAKEGEEAGP CCCHHHCCCCCCCCC | 63.30 | 21890473 | |
369 | Ubiquitination | PLLEAVPKTGDEKDV CHHHCCCCCCCCCCC | 59.55 | - | |
370 | Phosphorylation | LLEAVPKTGDEKDVS HHHCCCCCCCCCCCC | 43.74 | 23917254 | |
374 | Ubiquitination | VPKTGDEKDVSV--- CCCCCCCCCCCC--- | 69.07 | 21890473 | |
377 | Phosphorylation | TGDEKDVSV------ CCCCCCCCC------ | 32.04 | 23401153 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
4 | Y | Phosphorylation | Kinase | YES | P07947 | PSP |
13 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
13 | S | Phosphorylation | Kinase | CSNK2A2 | P19784 | GPS |
13 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
13 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
97 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
298 | Y | Phosphorylation | Kinase | YES1 | P07947 | GPS |
339 | S | Phosphorylation | Kinase | ULK1 | O75385 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CDC37_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDC37_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-13, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-45; LYS-78; LYS-154; LYS-240AND LYS-330, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-13, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-298, AND MASSSPECTROMETRY. |